ONCOLife Issues
Featured Articles
Trending Articles
FDA Approves Tecentriq–Zepzelca Combo as FL Maintenance Therapy for ES-SC Lung Cancer
FDA & EMA | 3 October 2025
Dr. Eleni Lagkadinou Discusses How AbbVie Is Advancing Targeted Innovation for HT Cancers
ONCOLife | 1 October 2025
DESTINY-Breast05: Enhertu Outperforms T-DM1 in High-Risk HER2+ Early Breast Cancer
FDA & EMA | 1 October 2025
Giredestrant Plus Everolimus Improves PF Survival in ER+ Advanced Breast Cancer
ONCOLife | 26 September 2025
The V Foundation and CVC Collaborate to Advance Breast Cancer Vaccine Research
ONCOLife | 12 September 2025
NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer
Clinical Trials | 20 September 2025
EMA’s CHMP Backs Subcutaneous Pembrolizumab in Head and Neck Cancer
FDA & EMA | 19 September 2025
GSK to invest $30 billion in R&D and Manufacturing in the US over next 5 years
Pharma | 18 September 2025
Climate-Driven Health Risks to Put $1.5 Trillion in Productivity at Stake by 2050
Opinion | 18 September 2025
The Role of Third-Generation TKIs in Overcoming Chronic Myeloid Leukemia Resistance
ONCOLife | 17 September 2025
SUNMO Trial: A New Chapter for Transplant-Ineligible Large B-Cell Lymphoma
ONCOLife | 15 September 2025
The V Foundation for Cancer Research and CVC Partner to Accelerate Breast Cancer Vaccines
ONCOLife
29 August 2025
FDA Grants Breakthrough Status to Izalontamab Brengitecan for EGF+ Lung Cancer
FDA & EMA
20 August 2025
The First FDA-Cleared Blood Test for Alzheimer’s Diagnosis Now Available on the Market
Neurology
19 August 2025
Ferroptosis as a New Strategy: Iron-Driven Cell Death Targets Cancer Stem Cells
ONCOLife
17 August 2025
Redesigned CD40 Antibody Triggers Systemic Tumor Regression and Complete Remission
ONCOLife
15 August 2025
RNA Isoform RUNX1C Identified as Molecular 'Switch' Behind Chemoresistance in Blood Cancer
ONCOLife
16 August 2025
FDA Grants Accelerated Approval to Semaglutide for MASH with Liver Fibrosis
FDA & EMA
16 August 2025
mRNA Vaccines Plus Checkpoint Inhibitors Shows Curative Potential in Gastric Cancer
ONCOLife
15 August 2025
FDA Approves Papzimeos, First Immunotherapy for Recurrent Respiratory Papillomatosis
FDA & EMA
15 August 2025
Breaking the Molecular Link Between Alcohol and Pancreatic Cancer by Targeting CREB
Clinical Trials
13 August 2025
PADCEV–KEYTRUDA Combination Delivers Survival Gains in High-Risk Bladder Cancer
ONCOLife
12 August 2025